About ASMS

About Member-at-Large Publications

The Member-at-Large (MAL) for Publications serves a two-year term. Their duties and responsibilities include:

  1. Chairs the Publications Committee;
  2. Serves as Board Liaison to the publisher of JASMS and the editors;
  3. Coordinates with MAL for Education and Digital Communications with respect to educational electronic and print publications, including the Classic Book series;
  4. Coordinates meetings and proceedings the ad hoc committee to select the Hites Award for outstanding research paper in JASMS.

Return to Board of Directors Election page to learn about other roles and their nominees.

Candidates for Member-at-Large Publications

Chen 2_96dpi

Guodong Chen

Bristol Myers Squibb

Candidate Statement
I have over 20 years of industry experience in applications of mass spectrometry. If elected to the board of Directors, I will seek to advance ASMS initiatives including publication strategies with the aim to enhance interactions and collaborations between academic and government researchers with industry scientists.

Guodong Chen, B.S. in Chemistry (University of Science and Technology of China); M.S. in Analytical Chemistry (West Virginia University with Professor Fred King); Ph.D. in Analytical Chemistry (Purdue University with Professor Graham Cooks). Dr. Chen has over 20 years of experience in the pharmaceutical industry, working at Eli Lilly, Schering-Plough and Bristol Myers Squibb with increasing responsibility. He is currently a Research Fellow at Bristol Myers Squibb in New Jersey.

Dr. Chen’s research interests include development and applications of mass spectrometry in drug discovery and development through internal efforts and global collaborations with academic and industrial partners. He has led the establishment of innovative industry-leading analytical capabilities for characterization and assay development for drug targets and therapeutic modalities including small molecules, peptides, biologics and novel modalities. His research efforts have emphasized higher order structure characterization, biophysical characterization, protein/drug interactions, epitope mapping and in vitro/in vivo liability assessment for drug candidate molecules. His work has resulted in over 90 peer-reviewed publications and book chapters. He has edited/co-edited three books on mass spectrometry: “Characterization of Protein Therapeutics Using Mass Spectrometry” (Springer), “Protein and Peptide Mass Spectrometry in Drug Discovery” (Wiley), and “Characterization of Impurities and Degradants Using Mass Spectrometry” (Wiley). He holds more than 30 U.S. patents (issued/pending).

Dr. Chen has organized and chaired sessions at scientific forums, including ASMS, ACS, Pittcon, EAS, CPSA and HOS. He has served as Program Chair for 2016 ASMS Sanibel Conference and on two ASMS Award selection committees. He has been coordinator of the ASMS Biotherapeutics Interest Group and Chair for North Jersey Mass Spectrometry Discussion Group. He has taught short courses on mass spectrometry at ASMS, Pittcon and EAS. Currently, Dr. Chen is on the Board of Associate Directors for CASSS and is a member of the Organizing Committee for International Symposium on Higher Order Structure of Protein Therapeutics. He is also on the Editorial Board of JASMS.

Valentine

Stephen J. Valentine

West Virginia University

Candidate Statement
I am running for Member-at-Large for Publications on the ASMS Board of Directors.  Having experienced equal time in start-up companies and academia during my career, I will bring a fresh perspective to the ASMS Board of Directors with new ideas for broadening the appeal of ASMS publications (e.g., educational publications, website content, etc.). My commitment to the society has very much enriched my professional career, and my strong work ethic will allow me to be a highly effective board member.  I would very much appreciate your support in this endeavor.

Stephen J. Valentine, B.A. in Chemistry (Adams State College); Ph.D. in Chemistry (Indiana University with Professor David Clemmer); Senior Scientist (Beyond Genomics, Inc.); Vice President of Science and Technology (Predictive Physiology and Medicine, Inc.).  Dr. Valentine is currently an Associate Professor and an Eberly Family Distinguished Professor of Chemistry in the C. Eugene Bennett Department of Chemistry at West Virginia University.

Dr. Valentine’s research interests are centered on the development of new analytical strategies for structural and comparative ‘omics investigations.  In the area of biomolecular structure analysis, he has developed a powerful approach that couples ion mobility spectrometry (IMS) with gas-phase hydrogen deuterium exchange (HDX) and tandem mass spectrometry (MS/MS).  The addition of the gas-phase HDX to IMS permits the filtering of computer-generated ion structures based on comparisons with modeled ion collision cross sections and HDX reactivity.  More recently, for the field of comparative metabolomics, Dr. Valentine’s research efforts have focused on developing in-droplet chemistries (e.g., cation adduction and HDX) to enhance compound ionization and identification capabilities. The approach features the new capillary vibrating sharp-edge spray ionization (cVSSI) method which allows for instantaneous switching between precursor and reaction product ions in an online setup. Overall, his work has resulted in over 90 peer-reviewed publications.

Dr. Valentine has organized and chaired sessions on the application of mass spectrometric techniques at national ASMS, ACS, and SciX conferences.  Additionally, he helped to organize three ASMS workshops for the Ion Mobility Interest Group. and has served on the program committee and as an Interest Group Coordinator.  Dr. Valentine has participated as an ad hoc reviewer for the NSF and NIH instrumentation grant review committees.  Currently, he serves as an Editorial Board Member of JASMS.